ALPHARONA® (interferon alpha-2b, 50,000 IU) identical with human interferon, has immunostimulating, antiviral, antiinflammatory and antimicrobial activity and is indicated for prevention and treatment of influenza and other ARVIs, especially, at early stages of the disease. The drug is allowed both for children from the first days of life and adults. The drug is administered intranasally (nasal drops).
Form of release, composition and packaging
Lyophilizate for preparation of solution for intranasal administration,
5 ml vial; polyethylene cover-dropper in a cardboard box.
Indications for use
Prevention and treatment of ARVI and influenza in adults and children at initial stages of the disease.
Individual intolerance of interferon drugs, severe forms of allergic diseases.